National Jewish Health is designated by the State of Colorado to administer the medication bamlanivimab to qualified patients diagnosed with COVID-19. The Infusion Center for COVID-19 Care is a designated COVID-19 patient care area dedicated to the delivery of bamlanivimab infusions.
Please wear a cloth or medical mask when you come for your appointment. Wearing a mask is mandatory for all patients receiving care at National Jewish Health.
We require you to provide a driver for your appointment. Your driver will deliver you to your appointment and pick you up from your appointment approximately four (4) hours later. No visitors are allowed in the National Jewish Health treatment unit.
When you and your driver arrive, please stay in your car. Clinical staff will greet you; please tell them that you are here for COVID-19 infusion treatment. The staff member will notify the unit that you are here. Please remain in your car until a member of the infusion center team comes to your car to escort you to the unit.
When you arrive at the Infusion Center for COVID-19 Care a medical provider will visit with you to understand your health history and to answer questions you may have regarding your treatment.
What is bamlanivimab? Bamlanivimab is an investigational medicine used for the treatment of COVID-19 in non-hospitalized adults and adolescents 12 years of age and older with mild to moderate symptoms and who are at high risk for developing severe COVID-19 symptoms or the need for hospitalization.
How will I receive bamlanivimab? Bamlanivimab is given to you through a vein (intravenous or IV). The infusion will take at least one (1) hour. You will receive one dose of bamlanivimab by IV infusion.
After your bamlanibimab infusion you will be monitored by nursing for a recovery period of one (1) hour.
During your recovery period the nursing team will help you contact your driver with an estimate of when your driver may pick you up. You will be escorted to your car by the care team staff.
You will be scheduled for a follow-up telemedicine appointment prior to leaving National Jewish Health. National Jewish Health will also provide confirmation of your treatment back to your referring physician.
For more information, view the FDA Fact Sheet for Patients, Parents and Caregivers Emergency Use Authorization (EUA) of Bamlanivimab for Coronavirus Disease 2019 (COVID-19).
Learn more about COVID-19 and how it affects specific health conditions in these printable patient education materials.
Download COVID-19 Materials